tiprankstipranks
Trending News
More News >
Propanc Biopharma (PPCB)
NASDAQ:PPCB
US Market

Propanc Biopharma (PPCB) Income Statement

Compare
64 Followers

Propanc Biopharma Income Statement

Last quarter (Q2 2026), Propanc Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Propanc Biopharma's net income was $-3.09M. See Propanc Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -21.66K$ -17.76K$ -5.67K$ 0.00
Operating Expenses
$ 57.28M$ 1.51M$ 1.76M$ 1.99M$ 1.81M
Depreciation and Amortization
$ 20.19K$ 21.66K$ 22.93K$ 1.99K$ 1.99K
EBITDA
$ -58.34M$ -1.26M$ -2.23M$ -2.14M$ -1.69M
Operating Income
$ -57.28M$ -1.54M$ -1.78M$ -1.99M$ -1.81M
Other Income/Expenses
$ -1.65M$ -414.00K$ -1.01M$ -722.00K$ -327.00K
Pretax Income
$ -58.92M$ -1.95M$ -2.79M$ -2.71M$ -2.14M
Net Income
$ -58.92M$ -1.82M$ -2.66M$ -2.66M$ -2.03M
Per Share Metrics
Basic EPS
$ -14.85$ -1.42K$ -31.27K$ -1.12M$ -800.00
Diluted EPS
$ -14.85$ -1.20K$ -31.27K$ -1.12M$ -800.00
Weighted Average Shares Outstanding
3.97M 1.42K 100.00 3.00 3.03K
Weighted Average Shares Outstanding (Diluted)
3.97M 1.42K 100.00 3.00 3.03K
Currency in USD

Propanc Biopharma Earnings and Revenue History